Rossari Biotech Share Price Today

Rossari Biotech to host analyst meet at Anand Rathi conference

Rossari Biotech to hold investor meet on September 22, 2026. Session part of Anand Rathi Annual Flagship Conference G-200 Summit. Meeting scheduled for 2:00 pm IST in Mumbai. No unpublished price-sensitive information will be disclosed.

Rossari Biotech withdraws from Nirmal Bang investor meet on Aug 10

Rossari Biotech Limited informed stock exchanges on August 06, 2026, that it will not participate in the Nirmal Bang Semi-Annual Investor Conference scheduled for August 10. This reverses a prior disclosure made on August 03 regarding the company's planned attendance for one-on-one and group sessions in Mumbai.

Rossari Biotech Q1FY27 revenue surges 28% to ₹697.2 crore

Rossari Biotech Limited reported its highest-ever quarterly revenue of ₹697.2 crore for Q1FY27, a 28% increase year-on-year. Consolidated PAT stood at ₹35.1 crore, up 4%, while EBITDA rose 18.7% to ₹80.6 crore, though margins contracted to 11.6%. Management maintained FY27 top-line growth guidance at 15% and targeted 15%+ EBITDA margins in two years. The Board approved ESOP grants and an internal restructuring involving the transfer of a subsidiary to Rossari (Singapore) Pte. Ltd.

Rossari Biotech declares dividend at 17th AGM

Rossari Biotech held its 17th AGM on July 20, 2026, approving a dividend of Re. 0.50 per share for FY26. Shareholders passed all eight resolutions, including the adoption of financial statements, the appointment of Mr. Udeypaul Singh Gill and re-appointment of Ms. Esha Padmanabhan Achan as Independent Directors, and the ratification of Cost Auditors. The meeting was conducted via video conferencing with remote e-voting available from July 17 to July 19.

Rossari Biotech Cites El Niño Headwinds in Agriculture Sector, Flags Global Uncertainty

Rossari Biotech has flagged that the agriculture sector is facing challenges due to the El Niño weather phenomenon. The company also stated that global uncertainty makes it difficult to predict revenue and profit growth. These factors collectively point to a cautious near-term outlook for the company's operations.

Rossari Biotech fixes record date for FY26 dividend of Re. 0.50

Rossari Biotech has announced Friday, July 10, 2026, as the record date for a final dividend of Re. 0.50 per equity share for the financial year ended March 31, 2026. The dividend is subject to shareholder approval at the 17th Annual General Meeting scheduled for Monday, July 20, 2026, via video conferencing. Remote e-voting will be open from July 17 to July 19, 2026.